All Posts
FDA Remediation Consulting: How to Recover From Compliance Setbacks and Stay Audit-Ready
When a pharmaceutical or life sciences company receives a Form 483, Warning Letter, or Consent
May 12, 2026
When a pharmaceutical or life sciences company receives a Form 483, Warning Letter, or Consent
Pharmacovigilance consulting has become a cornerstone of modern drug development and post-market surveillance. As regulatory
BOSTON, MA — May 6, 2026 — DES Pharma, a premier provider of strategic advisory
The countdown has officially begun. From May 11–14, 2026, the global biopharmaceutical community will descend
Grant Writing · Pharma & Drug Development · Complete Guide The Complete Guide
Biotech is the rare industry where a single decision — a missed FDA meeting, a
The pharmaceutical landscape is evolving rapidly, and staying ahead of the curve means keeping a
The Critical Bridge in Drug Development Technology transfer stands as one of the most pivotal—yet
Good Manufacturing Practice (GMP) is the lifeblood of the pharmaceutical industry. It is the minimum
For decades, the pharmaceutical industry operated under a singular, relentless mandate: efficiency. Pharmaceutical consultants have
Start building reliable, high-quality drug development programs today.